Connection

Baerbel Rohrer to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications Baerbel Rohrer has written about Immunotherapy, Adoptive.
Baerbel Rohrer
Connection Strength
0.125
Immunotherapy, Adoptive
  1. Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight. 2017 03 09; 2(5):e90772.
    View in: PubMed
    Score: 0.125
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.